MS News: September 2016

Image nerve cell

Below are some MS-related topics that made the headlines this month. Do come back to check again, though, as the list will be updated every three to five days.


  1. #ECTRIMS2016 – Congress on Latest in MS Research and Treatment Opens Sept. 14
  2. #ECTRIMS2016 – Stay Up to Date with My Pick of Congress Highlights
  3. 25 American Athletes To Watch At The Paralympics
  4. MRI key to distinguishing multiple sclerosis from its many mimics
  5. Trending Topics in Multiple Sclerosis

Pediatric MS

  1. Pediatric multiple sclerosis: meeting the needs of the young patient and the family
  2. Pediatric multiple sclerosis: observational trials show promise for interferon-beta and glatiramer
  3. Pediatric multiple sclerosis associated with cognitive impairment in approximately a third of patients
  4. Legal Planning & Care Planning For Young Multiple Sclerosis Patients Video


  1. Researchers use Google Glass to detect brain disorders
  2. Disease cluster hard to pinpoint when cause of illness is unknown
  3. MS Paper Critiqued
  4. Multiple sclerosis gene discovery comes under withering attack
  5. Migraine and Other ‘Common’ Ills Being Mistaken for MS, Study Finds
  6. Multiple Sclerosis Primary Research
  7. Multiple Sclerosis Primary Research Infographic Download
  8. Merck Launches New Gene Editing Technology to Engineer Virus Resistant CHO Cell Lines
  9. Biogen Demonstrates Commitment to Improving Patient Outcomes with Study on Burden of MS
  10. Research Paper On Multiple Sclerosis
  11. PhD Studentships in Motor Neurone Disease and Multiple Sclerosis
  12. $350000 Awarded to Next Generation of Multiple Sclerosis Researchers
  13. More than 35 Presentations of New data from Sanofi Genzyme’s Multiple Sclerosis …
  14. Deciphering the role of DNA methylation in multiple sclerosis
  15. Why vitamin D is so important
  16. USC Led Stem Cell Therapy Shows Regenerative Hope For Stroke, ALS, Multiple Sclerosis
  17. Myeloid Cells Key to MS?
  18. Virtually reality simplifies early diagnosis of multiple sclerosis and Parkinson’s disease
  19. Amino Acids in Cancer Metabolism and Neuroscience
  20. MS Treatments May Lower Levels of Immune White Blood Cells

Clinical Trials

  1. MS trials baseline
  2. Multiple sclerosis: age, viral copies tied to poor outcome in natalizumab-associated PML
  3. MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study

Treatment News

  1. 1st Generic for Copaxone to Treat Relapsing MS Available in Central and Eastern Europe
  2. Alvogen Launches First Generic Equivalent of CopaxoneTM in Europe
  3. Tamoxifen ‘could promote myelin repair’
  4. Optic neuritis
  5. Pediatric Multiple Sclerosis
  6. Multiple sclerosis: 5 ways to cut treatment costs and enhance care
  7. Emerging Oral Therapies in MS

Stem Cell Treatment

  1. FDA, at Last, Turns Its Attention to Stem Cell Therapies for PF and Other Chronic Ills

General news

  1. FDNY union wants autoimmune illnesses added to 9/11 list
  2. Why the misdiagnosis of multiple sclerosis (MS) is common
  3. Neurologists frequently misdiagnose multiple sclerosis
  4. Do Invisible Health Problems Exist?
  5. Does AbbVie Inc’s (ABBV) Tumor Drug Pipeline Have Solid Future Prospects?
  6. PTAB invalidates three patents covering Teva’s Copaxone, opens door for Mylan’s generic version
  7. MS, Spinal Injuries Highlighted at Paralyzed Veterans of America Summit
  8. FDA weighs crackdown that could shut stem cell clinics
  9. Improved Clinician Education Needed in Multiple Sclerosis Misdiagnosis
  10. Gladstone investigator receives $5.8M career grant
  11. FDA clears icometrix’ image quantification software to monitor neurological disorders
  12. Cluster or coincidence? Biostatistician weighs in on Elmvale Acres MS cluster claim
  13. Burden of multiple sclerosis increasing in Iran
  14. Gary Cutter, PhD
  15. 4 Types Of Headaches You Never Knew Existed And How To Cure Them

News posted on Barts MS Blog

  1. Best Blog 2016
  2. QuDoS in MS Awards. Blowing Your Trumpet
  3. Paralympic MS in the Medals
  4. ECTRIMS2016
  5. Practising for ECTRIMS
  6. ClinicSpeak & BrainHealth: how safe are your road-crossing skills?
  7. ClinicSpeak & #ThinkHand: who said progressive MS is not modfiable
  8. PoliticalSpeak: the risk-sharing scheme
  9. ResearchSpeak: Interferon vs. Alemtuzumab
  10. ResearchSpeak: converting from CIS to Multiple sclerosis
  11. Let’s Go Supercharged.
  12. Time to Reduce costs
  13. MD1003 biotin trial
  14. Restriction of fluid intake may make you tireder
  15. Predicting Progression: a combination of 4 outcomes does better than Imaging
  16. Eyes left
  17. A molecular switch between inflammation and regulation
  18. Risk of PML an alternative view

Mental Health

  1. The Mental Burden of Multiple Sclerosis
  2. Do You Keep Your Multiple Sclerosis to Yourself?
  3. MS Organizations to Help You Cope 
  4. Depression in Multiple Sclerosis 


  1. Sugar transforms a traditional Chinese medicine into a cruise missile
  2. Download The Multiple Sclerosis Diet Book PDF Download


  1. Spasticity and Exercise in MS


  1. Half of people with MS mistakenly accused of being drunk
  2. Half of people with MS have faced ‘unacceptable’ mistreatment
  3. Would you move your buggy? MS sufferers tell of ‘drunk’ accusations and bus arguments
  4. Lifestyle May Impact MS Disability, Study Suggests 
  5. Awards and likes and people on the fringes, we’re winning. MultipleSclerosis
  6. Being real!

When You’ve Just Been Diagnosed

  1. Diagnosing Multiple Sclerosis (MS)
  2. What is The Relapsing Remitting Multiple Sclerosis (MS) Disease Course
  3. The risk of developing MS

Business News

  1. Novartis’ BAF312 Successful in Multiple Sclerosis Study
  2. Biogen’s Latest Valuation Compared to Its Peers
  3. Biotech ETF Industry Outlook
  4. Teva to Present Latest Data in Multiple Sclerosis Research
  5. Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Upgraded to Outperform; Here’s Why
  6. How can Teva buck industry trends for 5% yearly generics growth? Launches–and lots of them
  7. One, two, three, gone: Teva loses third patent on new Copaxone formula
  8. Teva loses third US patent Multiple Sclerosis drug Copaxone
  9. GW Pharmaceuticals (GWPH) Closed Higher on Takeover Speculation
  10. Secondary Progressive Multiple Sclerosis Pipeline Review, Market Demand, Market Price


  1. Natural Treatments for Symptoms of Multiple Sclerosis

© Willeke Van Eeckhoutte and Ireland, Multiple Sclerosis & Me, 2011-2016. Unauthorised use and/or duplication of this material without express and written permission from this blog’s author and/or owner are strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Willeke Van Eeckhoutte and Ireland, Multiple Sclerosis & Me with appropriate and specific direction to the original content.

Posted by

Quirky, tenacious and neurologically compromised female expat living in Ireland since 2002 ◾ MyTherapyApp Best MS Blog for Simplicity 2018 ◾ Everyday Health Top 10 MS Blog of 2018 ◾ WEGO Health Patient Leader Award Nominee 2018 ◾ Feedspot Top 50 MS Blog 2017, 2018 ◾ Ireland Blog Award Finalist 2014, 2015, 2017 & Shortlisted 2018 (competition ongoing) ◾ Contributor to the Novartis MS blog Living Like You ◾ Contributor to MS Ireland’s blog MS & Me ◾ Contributor to The Mighty ◾ Guest contributor to

One thought on “MS News: September 2016

Your thoughts?

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.